Rtw Investments, Lp - Net Worth and Insider Trading

Rtw Investments, Lp Net Worth

The estimated net worth of Rtw Investments, Lp is at least $1.2 Billion dollars as of 2025-01-12. Rtw Investments, Lp is the 10% Owner of Prometheus Biosciences Inc and owns about 3,264,031 shares of Prometheus Biosciences Inc (RXDX) stock worth over $653 Million. Rtw Investments, Lp is the of Rocket Pharmaceuticals Inc and owns about 17,628,567 shares of Rocket Pharmaceuticals Inc (RCKT) stock worth over $196 Million. Rtw Investments, Lp is also the 10% Owner of Avidity Biosciences Inc and owns about 4,795,000 shares of Avidity Biosciences Inc (RNA) stock worth over $141 Million. Besides these, Rtw Investments, Lp also holds Tarsus Pharmaceuticals Inc (TARS) , Stoke Therapeutics Inc (STOK) , Renovacor Inc (RCOR) , Landos Biopharma Inc (LABP) , Milestone Pharmaceuticals Inc (MIST) , TELA Bio Inc (TELA) , Athira Pharma Inc (ATHA) , DermTech Inc (DMTKQ) . Details can be seen in Rtw Investments, Lp's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rtw Investments, Lp has not made any transactions after 2022-11-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Rtw Investments, Lp

Rtw Investments, Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rtw Investments, Lp owns 15 companies in total, including Athira Pharma Inc (ATHA) , DermTech Inc (CNACU) , and Milestone Pharmaceuticals Inc (MIST) among others .

Click here to see the complete history of Rtw Investments, Lp’s form 4 insider trades.

Insider Ownership Summary of Rtw Investments, Lp

Ticker	Comapny	Transaction Date	Type of Owner
ATHA	Athira Pharma Inc	2020-09-18	10 percent owner
CNACU	DermTech Inc	2020-08-17	10 percent owner
MIST	Milestone Pharmaceuticals Inc	2022-09-07	10 percent owner
		2021-08-04	10 percent owner
		2019-12-17	10 percent owner
		2022-10-06	10 percent owner
		2019-11-08	10 percent owner
		2021-05-07	10 percent owner
		2022-11-04	10 percent owner
		2021-03-16	10 percent owner
		2022-09-23	10 percent owner
		2022-01-18	10 percent owner
		2021-11-04	10 percent owner
		2023-01-24	10 percent owner
		2023-01-24	10 percent owner

Rtw Investments, Lp Latest Holdings Summary

Rtw Investments, Lp currently owns a total of 11 stocks. Among these stocks, Rtw Investments, Lp owns 3,264,031 shares of Prometheus Biosciences Inc (RXDX) as of March 16, 2021, with a value of $653 Million and a weighting of 56.23%. Rtw Investments, Lp owns 17,628,567 shares of Rocket Pharmaceuticals Inc (RCKT) as of October 6, 2022, with a value of $196 Million and a weighting of 16.92%. Rtw Investments, Lp also owns 4,795,000 shares of Avidity Biosciences Inc (RNA) as of August 4, 2021, with a value of $141 Million and a weighting of 12.17%. The other 8 stocks Tarsus Pharmaceuticals Inc (TARS) , Stoke Therapeutics Inc (STOK) , Renovacor Inc (RCOR) , Landos Biopharma Inc (LABP) , Milestone Pharmaceuticals Inc (MIST) , TELA Bio Inc (TELA) , Athira Pharma Inc (ATHA) , DermTech Inc (DMTKQ) have a combined weighting of 14.68% among all his current holdings.

Latest Holdings of Rtw Investments, Lp

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
RXDX	Prometheus Biosciences Inc	2021-03-16	3,264,031	199.92	652,545,078
RCKT	Rocket Pharmaceuticals Inc	2022-10-06	17,628,567	11.14	196,382,236
RNA	Avidity Biosciences Inc	2021-08-04	4,795,000	29.46	141,260,700
TARS	Tarsus Pharmaceuticals Inc	2021-05-07	2,013,601	52.69	106,096,637
STOK	Stoke Therapeutics Inc	2019-11-08	3,544,248	9.00	31,898,232
RCOR	Renovacor Inc	2022-01-18	3,000,803	3.20	9,602,570
LABP	Landos Biopharma Inc	2022-09-23	397,572	22.93	9,116,326
MIST	Milestone Pharmaceuticals Inc	2022-09-07	4,315,102	2.08	8,975,412
TELA	TELA Bio Inc	2019-12-17	1,139,358	2.81	3,201,596
ATHA	Athira Pharma Inc	2020-09-18	2,668,913	0.57	1,508,203
DMTKQ	DermTech Inc	2022-11-04	3,018,666	0.00	302

Holding Weightings of Rtw Investments, Lp

Rtw Investments, Lp Form 4 Trading Tracker

According to the SEC Form 4 filings, Rtw Investments, Lp has made a total of 1 transactions in Prometheus Biosciences Inc (RXDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Prometheus Biosciences Inc is the acquisition of 800,000 shares on March 16, 2021, which cost Rtw Investments, Lp around $15 Million.

According to the SEC Form 4 filings, Rtw Investments, Lp has made a total of 3 transactions in Rocket Pharmaceuticals Inc (RCKT) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Rocket Pharmaceuticals Inc is the acquisition of 1,355,932 shares on October 6, 2022, which cost Rtw Investments, Lp around $20 Million.

According to the SEC Form 4 filings, Rtw Investments, Lp has made a total of 2 transactions in Avidity Biosciences Inc (RNA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Avidity Biosciences Inc is the acquisition of 800,000 shares on August 4, 2021, which cost Rtw Investments, Lp around $14 Million.

More details on Rtw Investments, Lp's insider transactions can be found in the Insider Trading History of Rtw Investments, Lp table.

Insider Trading History of Rtw Investments, Lp

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rtw Investments, Lp Trading Performance

GuruFocus tracks the stock performance after each of Rtw Investments, Lp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rtw Investments, Lp is -16.35%. GuruFocus also compares Rtw Investments, Lp's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rtw Investments, Lp within 3 months outperforms 12 times out of 36 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rtw Investments, Lp's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rtw Investments, Lp

Average Return

Average return per transaction

Outperforming Transactions

10 out of 30 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-5.28
Relative Return to S&P 500(%)	-4.9

Rtw Investments, Lp Ownership Network

Ownership Network List of Rtw Investments, Lp

No Data

Ownership Network Relation of Rtw Investments, Lp

Rtw Investments, Lp Owned Company Details

What does Athira Pharma Inc do?

Who are the key executives at Athira Pharma Inc?

Rtw Investments, Lp is the 10 percent owner of Athira Pharma Inc. Other key executives at Athira Pharma Inc include Chief Operating Officer Mark James Litton , Vice President of Discovery Kevin Church , and General Counsel Mark Worthington .

Athira Pharma Inc (ATHA) Insider Trades Summary

Over the past 18 months, Rtw Investments, Lp made no insider transaction in Athira Pharma Inc (ATHA). Other recent insider transactions involving Athira Pharma Inc (ATHA) include a net sale of 39,779 shares made by Mark James Litton , a net sale of 15,859 shares made by Mark Worthington , and a net sale of 13,447 shares made by Kevin Church .

In summary, during the past 3 months, insiders sold 55,834 shares of Athira Pharma Inc (ATHA) in total and bought 0 shares, with a net sale of 55,834 shares. During the past 18 months, 92,621 shares of Athira Pharma Inc (ATHA) were sold and 648,086 shares were bought by its insiders, resulting in a net purchase of 555,465 shares.

Athira Pharma Inc (ATHA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Athira Pharma Inc Insider Transactions

No Available Data

What does DermTech Inc do?

Who are the key executives at DermTech Inc?

Rtw Investments, Lp is the 10 percent owner of DermTech Inc. Other key executives at DermTech Inc include Chief Commercial Officer Todd Michael Wood , director & Chief Executive Officer John Dobak , and Chief Operating Officer Claudia Ibarra .

DermTech Inc (CNACU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of DermTech Inc (CNACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DermTech Inc (CNACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DermTech Inc (CNACU)'s detailed insider trading history can be found in Insider Trading Tracker table.

DermTech Inc Insider Transactions

No Available Data

What does Milestone Pharmaceuticals Inc do?

Who are the key executives at Milestone Pharmaceuticals Inc?

Rtw Investments, Lp is the 10 percent owner of Milestone Pharmaceuticals Inc. Other key executives at Milestone Pharmaceuticals Inc include Chief Medical Officer David Bharucha , 10 percent owner Roderick Wong , and Chief Operating Officer Jeffrey Edward Nelson .

Milestone Pharmaceuticals Inc (MIST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Milestone Pharmaceuticals Inc (MIST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Milestone Pharmaceuticals Inc (MIST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Milestone Pharmaceuticals Inc (MIST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Milestone Pharmaceuticals Inc Insider Transactions

No Available Data

What does Avidity Biosciences Inc do?

Who are the key executives at Avidity Biosciences Inc?

Rtw Investments, Lp is the 10 percent owner of Avidity Biosciences Inc. Other key executives at Avidity Biosciences Inc include Chief Financial Officer Michael F Maclean , director & President and CEO Sarah Boyce , and Chief Human Resources Officer Teresa Mccarthy .

Avidity Biosciences Inc (RNA) Insider Trades Summary

Over the past 18 months, Rtw Investments, Lp made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 192,823 shares made by Arthur A Levin , a net sale of 653,901 shares made by Sarah Boyce , and a net sale of 361,069 shares made by Michael F Maclean .

In summary, during the past 3 months, insiders sold 280,541 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 280,541 shares. During the past 18 months, 1,623,897 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,623,897 shares.

Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Avidity Biosciences Inc Insider Transactions

No Available Data

What does TELA Bio Inc do?

Who are the key executives at TELA Bio Inc?

Rtw Investments, Lp is the 10 percent owner of TELA Bio Inc. Other key executives at TELA Bio Inc include Chief Business Officer Gregory A. Firestone , COO and CFO Roberto Cuca , and Chief Strategic Officer Paul Talmo .

TELA Bio Inc (TELA) Insider Trades Summary

Over the past 18 months, Rtw Investments, Lp made no insider transaction in TELA Bio Inc (TELA). Other recent insider transactions involving TELA Bio Inc (TELA) include a net purchase of 99,888 shares made by Antony Koblish , a net purchase of 74,444 shares made by Roberto Cuca , and a net purchase of 9,266 shares made by Gregory A. Firestone .

In summary, during the past 3 months, insiders sold 0 shares of TELA Bio Inc (TELA) in total and bought 182,220 shares, with a net purchase of 182,220 shares. During the past 18 months, 428,300 shares of TELA Bio Inc (TELA) were sold and 205,820 shares were bought by its insiders, resulting in a net sale of 222,480 shares.

TELA Bio Inc (TELA)'s detailed insider trading history can be found in Insider Trading Tracker table.

TELA Bio Inc Insider Transactions

No Available Data

What does Rocket Pharmaceuticals Inc do?

Who are the key executives at Rocket Pharmaceuticals Inc?

Rtw Investments, Lp is the 10 percent owner of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include General Counsel Martin Wilson , director & See Remarks Gaurav Shah , and See Remarks John Militello .

Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary

Over the past 18 months, Rtw Investments, Lp made no insider transaction in Rocket Pharmaceuticals Inc (RCKT). Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 23,716 shares made by John Militello , a net sale of 55,570 shares made by Gaurav Shah , and a net sale of 21,289 shares made by Kinnari Patel .

In summary, during the past 3 months, insiders sold 22,075 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 0 shares, with a net sale of 22,075 shares. During the past 18 months, 793,128 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 793,128 shares.

Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rocket Pharmaceuticals Inc Insider Transactions

No Available Data

What does Stoke Therapeutics Inc do?

Who are the key executives at Stoke Therapeutics Inc?

Rtw Investments, Lp is the 10 percent owner of Stoke Therapeutics Inc. Other key executives at Stoke Therapeutics Inc include 10 percent owner Skorpios Trust , General Counsel & Corp Sec Jonathan Allan , and director & CEO Kaye Edward M. Md .

Stoke Therapeutics Inc (STOK) Insider Trades Summary

Over the past 18 months, Rtw Investments, Lp made no insider transaction in Stoke Therapeutics Inc (STOK). Other recent insider transactions involving Stoke Therapeutics Inc (STOK) include a net sale of 130,647 shares made by Barry Ticho , a net sale of 39,436 shares made by Jonathan Allan , and a net sale of 66,456 shares made by Kaye Edward M. Md .

In summary, during the past 3 months, insiders sold 2,072,849 shares of Stoke Therapeutics Inc (STOK) in total and bought 0 shares, with a net sale of 2,072,849 shares. During the past 18 months, 7,834,771 shares of Stoke Therapeutics Inc (STOK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,834,771 shares.

Stoke Therapeutics Inc (STOK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Stoke Therapeutics Inc Insider Transactions

No Available Data

What does Tarsus Pharmaceuticals Inc do?

Who are the key executives at Tarsus Pharmaceuticals Inc?

Rtw Investments, Lp is the 10 percent owner of Tarsus Pharmaceuticals Inc. Other key executives at Tarsus Pharmaceuticals Inc include See Remarks Jeffrey S Farrow , Chief Human Resources Officer Dianne C. Whitfield , and General Counsel Bryan Wahl .

Tarsus Pharmaceuticals Inc (TARS) Insider Trades Summary

Over the past 18 months, Rtw Investments, Lp made no insider transaction in Tarsus Pharmaceuticals Inc (TARS). Other recent insider transactions involving Tarsus Pharmaceuticals Inc (TARS) include a net sale of 194,315 shares made by Bobak R. Azamian , a net sale of 12,792 shares made by Bryan Wahl , and a net sale of 12,669 shares made by Dianne C. Whitfield .

In summary, during the past 3 months, insiders sold 0 shares of Tarsus Pharmaceuticals Inc (TARS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 281,122 shares of Tarsus Pharmaceuticals Inc (TARS) were sold and 10,506 shares were bought by its insiders, resulting in a net sale of 270,616 shares.

Tarsus Pharmaceuticals Inc (TARS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Tarsus Pharmaceuticals Inc Insider Transactions

No Available Data

What does DermTech Inc do?

Who are the key executives at DermTech Inc?

Rtw Investments, Lp is the 10 percent owner of DermTech Inc. Other key executives at DermTech Inc include Chief Financial Officer Kevin M Sun , Chief Operating Officer Claudia Ibarra , and General Counsel Ramin Akhavan .

DermTech Inc (DMTKQ) Insider Trades Summary

Over the past 18 months, Rtw Investments, Lp made no insider transaction in DermTech Inc (DMTKQ). Other recent insider transactions involving DermTech Inc (DMTKQ) include a net sale of 15,042 shares made by Kevin M Sun , a net sale of 14,549 shares made by Claudia Ibarra , and a net sale of 8,299 shares made by Ramin Akhavan .

In summary, during the past 3 months, insiders sold 0 shares of DermTech Inc (DMTKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,890 shares of DermTech Inc (DMTKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,890 shares.

DermTech Inc (DMTKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

DermTech Inc Insider Transactions

No Available Data

What does Prometheus Biosciences Inc do?

Who are the key executives at Prometheus Biosciences Inc?

Rtw Investments, Lp is the 10 percent owner of Prometheus Biosciences Inc. Other key executives at Prometheus Biosciences Inc include Chief Financial Officer Keith W Marshall , director & President and CEO Mark C. Mckenna , and 10 percent owner Cedars Sinai Intellectual Property Co .

Prometheus Biosciences Inc (RXDX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Prometheus Biosciences Inc Insider Transactions

No Available Data

What does Landos Biopharma Inc do?

Who are the key executives at Landos Biopharma Inc?

Rtw Investments, Lp is the 10 percent owner of Landos Biopharma Inc. Other key executives at Landos Biopharma Inc include 10 percent owner Perceptive Xontogeny Venture Fund Ii, Lp , 10 percent owner Roderick Wong , and Chief Medical Officer Fabio Cataldi .

Landos Biopharma Inc (LABP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Landos Biopharma Inc (LABP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Landos Biopharma Inc (LABP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Landos Biopharma Inc (LABP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Landos Biopharma Inc Insider Transactions

No Available Data

What does Renovacor Inc do?

Who are the key executives at Renovacor Inc?

Rtw Investments, Lp is the 10 percent owner of Renovacor Inc. Other key executives at Renovacor Inc include Chief Accounting Officer Joseph S Carroll , Chief Financial Officer Frederick W Driscoll , and director & Chief Executive Officer Magdalene Cook .

Renovacor Inc (RCOR) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Renovacor Inc (RCOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Renovacor Inc (RCOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Renovacor Inc (RCOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Renovacor Inc Insider Transactions

No Available Data

What does Chardan Healthcare Acquisition 2 Corp do?

Who are the key executives at Chardan Healthcare Acquisition 2 Corp?

Rtw Investments, Lp is the 10 percent owner of Chardan Healthcare Acquisition 2 Corp. Other key executives at Chardan Healthcare Acquisition 2 Corp include Chief Accounting Officer Joseph S Carroll , Chief Financial Officer Frederick W Driscoll , and director & Chief Executive Officer Magdalene Cook .

Chardan Healthcare Acquisition 2 Corp (CHAQ.U) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Chardan Healthcare Acquisition 2 Corp (CHAQ.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Chardan Healthcare Acquisition 2 Corp (CHAQ.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Chardan Healthcare Acquisition 2 Corp (CHAQ.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Chardan Healthcare Acquisition 2 Corp Insider Transactions

No Available Data

What does Health Sciences Acquisitions Corp 2 do?

Who are the key executives at Health Sciences Acquisitions Corp 2?

Rtw Investments, Lp is the 10 percent owner of Health Sciences Acquisitions Corp 2. Other key executives at Health Sciences Acquisitions Corp 2 include director & See Remarks David P Hochman , Chief Financial Officer Michael Kaswan , and director & See Remarks Darren Sherman .

Health Sciences Acquisitions Corp 2 (HSAQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Health Sciences Acquisitions Corp 2 (HSAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Health Sciences Acquisitions Corp 2 (HSAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Health Sciences Acquisitions Corp 2 (HSAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Health Sciences Acquisitions Corp 2 Insider Transactions

No Available Data

What does Orchestra BioMed Holdings Inc do?

Who are the key executives at Orchestra BioMed Holdings Inc?

Rtw Investments, Lp is the 10 percent owner of Orchestra BioMed Holdings Inc. Other key executives at Orchestra BioMed Holdings Inc include director & See Remarks David P Hochman , Chief Financial Officer Andrew Lawrence Taylor , and director & See Remarks Darren Sherman .

Orchestra BioMed Holdings Inc (OBIO) Insider Trades Summary

Over the past 18 months, Rtw Investments, Lp made no insider transaction in Orchestra BioMed Holdings Inc (OBIO). Other recent insider transactions involving Orchestra BioMed Holdings Inc (OBIO) include a net purchase of 27,500 shares made by David P Hochman , a net sale of 34,325 shares made by Darren Sherman , and a net sale of 5,600 shares made by Eric S Fain .

In summary, during the past 3 months, insiders sold 0 shares of Orchestra BioMed Holdings Inc (OBIO) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 39,925 shares of Orchestra BioMed Holdings Inc (OBIO) were sold and 32,500 shares were bought by its insiders, resulting in a net sale of 7,425 shares.

Orchestra BioMed Holdings Inc (OBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Orchestra BioMed Holdings Inc Insider Transactions

No Available Data

Rtw Investments, Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Rtw Investments, Lp. You might contact Rtw Investments, Lp via mailing address: 40 10th Avenue, 7th Floor, New York Ny 10014.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.